If you’re marketing into healthcare or life sciences, the standard B2B playbook doesn’t really apply. At least not in the typical sense. That’s because your buyer is buying more than just software. They’re also buying risk reduction and a faster route to the outcomes their particular department or function is tasked with. Take the clinical development group in pharma for example. Nobody in ClinOps is as excited about that new widget or a cleaner UI as you are. What they care

Executive Summary: Past tactics no longer work Capital is tighter, buyer attention is scarcer, and AI has reset the rules. In three roundtables with eighteen CMOs, VPs of Marketing, and GTM leaders, one theme dominated: yesterday’s tried-and-true tactics no longer earn tomorrow’s pipeline. Despite these challenges, a few things emerged that showed how these same leaders move the needle. They shared 10 practical strategies that are already producing double-digit lift in demo c